Published in Oncogene on January 23, 2012
The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol (2012) 5.60
MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov (2013) 3.33
LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res (2012) 2.73
Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet (2013) 2.59
ChIPBase: a database for decoding the transcriptional regulation of long non-coding RNA and microRNA genes from ChIP-Seq data. Nucleic Acids Res (2012) 2.11
Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol (2012) 1.90
Expression and regulation of intergenic long noncoding RNAs during T cell development and differentiation. Nat Immunol (2013) 1.71
Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma. J Cancer Res Clin Oncol (2012) 1.66
The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell. PLoS One (2013) 1.65
Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Mol Cancer (2014) 1.59
Association of large intergenic noncoding RNA expression with disease activity and organ damage in systemic lupus erythematosus. Arthritis Res Ther (2015) 1.49
Low expression of LOC285194 is associated with poor prognosis in colorectal cancer. J Transl Med (2013) 1.45
Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival. PLoS One (2013) 1.44
MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J Clin (2014) 1.40
Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol (2014) 1.39
High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma. Int J Clin Exp Pathol (2014) 1.37
Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets. Mol Cell Ther (2015) 1.32
Large-scale East-Asian eQTL mapping reveals novel candidate genes for LD mapping and the genomic landscape of transcriptional effects of sequence variants. PLoS One (2014) 1.27
The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression. Mol Cancer (2015) 1.24
A long noncoding RNA connects c-Myc to tumor metabolism. Proc Natl Acad Sci U S A (2014) 1.20
Expression analysis and in silico characterization of intronic long noncoding RNAs in renal cell carcinoma: emerging functional associations. Mol Cancer (2013) 1.18
Exosomes as divine messengers: are they the Hermes of modern molecular oncology? Cell Death Differ (2014) 1.18
Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2. Mol Cancer (2015) 1.17
The intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation. PLoS Genet (2013) 1.14
Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer. Oncotarget (2014) 1.13
Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer. Oncotarget (2016) 1.11
Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis. Int J Clin Exp Pathol (2015) 1.10
Colon Cancer Associated Transcript-1 (CCAT1) Expression in Adenocarcinoma of the Stomach. J Cancer (2015) 1.07
Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Int J Clin Exp Pathol (2014) 1.05
Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer. Oncotarget (2016) 1.05
LincHOTAIR epigenetically silences miR34a by binding to PRC2 to promote the epithelial-to-mesenchymal transition in human gastric cancer. Cell Death Dis (2015) 1.04
Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma. J Transl Med (2014) 1.04
Transcriptome analysis reveals distinct patterns of long noncoding RNAs in heart and plasma of mice with heart failure. PLoS One (2013) 1.03
Noncoding RNA in oncogenesis: a new era of identifying key players. Int J Mol Sci (2013) 1.03
Long intergenic non-coding RNA HOTAIRM1 regulates cell cycle progression during myeloid maturation in NB4 human promyelocytic leukemia cells. RNA Biol (2014) 1.03
LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2. PLoS One (2014) 1.02
LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway. Oncotarget (2015) 0.99
Hormone-regulated transcriptomes: lessons learned from estrogen signaling pathways in breast cancer cells. Mol Cell Endocrinol (2013) 0.99
IRWRLDA: improved random walk with restart for lncRNA-disease association prediction. Oncotarget (2016) 0.96
LncRNA2Target: a database for differentially expressed genes after lncRNA knockdown or overexpression. Nucleic Acids Res (2014) 0.96
Long non-coding RNAs and their implications in cancer epigenetics. Biosci Rep (2013) 0.95
Constructing lncRNA functional similarity network based on lncRNA-disease associations and disease semantic similarity. Sci Rep (2015) 0.95
Induction of the liver cancer-down-regulated long noncoding RNA uc002mbe.2 mediates trichostatin-induced apoptosis of liver cancer cells. Biochem Pharmacol (2013) 0.95
The complexity of thyroid transcription factor 1 with both pro- and anti-oncogenic activities. J Biol Chem (2013) 0.94
The fusion of two worlds: non-coding RNAs and extracellular vesicles--diagnostic and therapeutic implications (Review). Int J Oncol (2014) 0.93
Long non-coding RNA Loc554202 induces apoptosis in colorectal cancer cells via the caspase cleavage cascades. J Exp Clin Cancer Res (2015) 0.93
A novel long non-coding RNA, hypoxia-inducible factor-2α promoter upstream transcript, functions as an inhibitor of osteosarcoma stem cells in vitro. Mol Med Rep (2014) 0.92
Noncoding RNAs in cancer and cancer stem cells. Chin J Cancer (2013) 0.92
LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma. Int J Clin Exp Pathol (2014) 0.92
Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis. Dig Dis Sci (2015) 0.92
Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients. Sci Rep (2016) 0.91
LncRNAWiki: harnessing community knowledge in collaborative curation of human long non-coding RNAs. Nucleic Acids Res (2014) 0.90
Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer. Biomed Res Int (2014) 0.90
Upregulation of H19 indicates a poor prognosis in gallbladder carcinoma and promotes epithelial-mesenchymal transition. Am J Cancer Res (2015) 0.90
Role of MALAT1 as a Prognostic Factor for Survival in Various Cancers: A Systematic Review of the Literature with Meta-Analysis. Dis Markers (2015) 0.90
Decoy activity through microRNAs: the therapeutic implications. Expert Opin Biol Ther (2012) 0.89
KATZLDA: KATZ measure for the lncRNA-disease association prediction. Sci Rep (2015) 0.89
Noncoding RNAs: key molecules in understanding and treating pain. Trends Mol Med (2014) 0.89
Long noncoding RNA-HOTAIR affects chemoresistance by regulating HOXA1 methylation in small cell lung cancer cells. Lab Invest (2015) 0.88
The role of MALAT1 correlates with HPV in cervical cancer. Oncol Lett (2014) 0.88
Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis. Mol Cancer (2016) 0.87
Long non-coding RNA HOTAIR is a marker for hepatocellular carcinoma progression and tumor recurrence. Oncol Lett (2016) 0.87
Microarray expression profiling of dysregulated long non-coding RNAs in triple-negative breast cancer. Cancer Biol Ther (2015) 0.87
The prognostic significance of HOTAIR for predicting clinical outcome in patients with digestive system tumors. J Cancer Res Clin Oncol (2015) 0.87
The long noncoding RNA CASC9 regulates migration and invasion in esophageal cancer. Cancer Med (2016) 0.86
Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer. Gut (2015) 0.86
Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer. Int J Clin Exp Pathol (2015) 0.86
Long Noncoding RNA Arid2-IR Is a Novel Therapeutic Target for Renal Inflammation. Mol Ther (2015) 0.86
Long non-coding RNA CASC2 suppresses the proliferation of gastric cancer cells by regulating the MAPK signaling pathway. Am J Transl Res (2016) 0.86
A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma. Int J Clin Exp Pathol (2014) 0.85
Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression. Mol Cancer (2015) 0.85
Long noncoding RNAs and neuroblastoma. Oncotarget (2015) 0.85
CAGE profiling of ncRNAs in hepatocellular carcinoma reveals widespread activation of retroviral LTR promoters in virus-induced tumors. Genome Res (2015) 0.84
Computational prediction of polycomb-associated long non-coding RNAs. PLoS One (2012) 0.84
H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer. EBioMedicine (2016) 0.84
Histones and their modifications in ovarian cancer - drivers of disease and therapeutic targets. Front Oncol (2014) 0.84
Silencing of long noncoding RNA AK139328 attenuates ischemia/reperfusion injury in mouse livers. PLoS One (2013) 0.83
New evidence of lncRNA role in tumor progression and metastasis. Hepatobiliary Surg Nutr (2012) 0.83
Minireview: Long noncoding RNAs: new "links" between gene expression and cellular outcomes in endocrinology. Mol Endocrinol (2013) 0.83
Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer. Oncotarget (2016) 0.83
TF2LncRNA: identifying common transcription factors for a list of lncRNA genes from ChIP-Seq data. Biomed Res Int (2014) 0.83
Long noncoding RNA AK126698 inhibits proliferation and migration of non-small cell lung cancer cells by targeting Frizzled-8 and suppressing Wnt/β-catenin signaling pathway. Onco Targets Ther (2016) 0.83
Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma. Int J Mol Sci (2015) 0.82
Lnc-CC3 increases metastasis in cervical cancer by increasing Slug expression. Oncotarget (2016) 0.82
A novel mitosis-associated lncRNA, MA-linc1, is required for cell cycle progression and sensitizes cancer cells to Paclitaxel. Oncotarget (2015) 0.82
Methods for the study of long noncoding RNA in cancer cell signaling. Methods Mol Biol (2014) 0.82
Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer. Medicine (Baltimore) (2016) 0.82
Developmental programming of long non-coding RNAs during postnatal liver maturation in mice. PLoS One (2014) 0.81
Upregulation of the long noncoding RNA UCA1 affects the proliferation, invasion, and survival of hypopharyngeal carcinoma. Mol Cancer (2017) 0.81
Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines. J Cell Mol Med (2015) 0.81
Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer cells through TGF-β/Smad signaling pathway. Oncotarget (2016) 0.81
Implication of lncRNAs in pathogenesis of esophageal cancer. Onco Targets Ther (2015) 0.80
Noncoding RNAs in Acute Myeloid Leukemia: From Key Regulators to Clinical Players. Scientifica (Cairo) (2012) 0.80
SomamiR 2.0: a database of cancer somatic mutations altering microRNA-ceRNA interactions. Nucleic Acids Res (2015) 0.80
Long noncoding RNA C17orf91 is a potential prognostic marker and functions as an oncogene in ovarian cancer. J Ovarian Res (2016) 0.79
Long noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanism. World J Hepatol (2015) 0.79
Regulation of mammary epithelial cell homeostasis by lncRNAs. Int J Biochem Cell Biol (2014) 0.79
Satellite non-coding RNAs: the emerging players in cells, cellular pathways and cancer. Chromosome Res (2015) 0.78
Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer. Onco Targets Ther (2016) 0.78
Decoding the usefulness of non-coding RNAs as breast cancer markers. J Transl Med (2016) 0.78
Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A (2009) 54.68
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature (2009) 35.48
Silencing of microRNAs in vivo with 'antagomirs'. Nature (2005) 32.56
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature (2010) 23.55
Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A (2009) 20.66
Long non-coding RNAs: insights into functions. Nat Rev Genet (2009) 19.61
RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science (2007) 18.59
Ultraconserved elements in the human genome. Science (2004) 17.14
Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev (2011) 16.77
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature (2010) 13.82
Long noncoding RNAs with enhancer-like function in human cells. Cell (2010) 13.00
A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell (2010) 12.27
Rfam: updates to the RNA families database. Nucleic Acids Res (2008) 11.61
lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature (2011) 11.31
Target mimicry provides a new mechanism for regulation of microRNA activity. Nat Genet (2007) 9.48
A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science (2005) 9.25
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature (2008) 8.38
The impact of retrotransposons on human genome evolution. Nat Rev Genet (2009) 8.08
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene (2003) 7.90
Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature (2008) 7.64
Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature (2008) 7.18
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet (2009) 6.99
Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell (2010) 6.94
RNA exosome depletion reveals transcription upstream of active human promoters. Science (2008) 6.80
Tsix, a gene antisense to Xist at the X-inactivation centre. Nat Genet (1999) 6.77
The genetic signatures of noncoding RNAs. PLoS Genet (2009) 6.72
Most "dark matter" transcripts are associated with known genes. PLoS Biol (2010) 6.60
Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science (2007) 6.33
A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics (2007) 6.28
Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res (2011) 6.02
The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet (2009) 5.65
Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature (2007) 5.57
Natural mutagenesis of human genomes by endogenous retrotransposons. Cell (2010) 5.50
MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol (2011) 5.46
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell (2007) 5.40
Genetic control by a metabolite binding mRNA. Chem Biol (2002) 4.85
Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal (2010) 4.77
The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell (2010) 4.71
Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology (2006) 4.70
CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res (2010) 4.68
DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res (1999) 4.67
3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell (2008) 4.54
Altered nuclear retention of mRNAs containing inverted repeats in human embryonic stem cells: functional role of a nuclear noncoding RNA. Mol Cell (2009) 4.54
lncRNAdb: a reference database for long noncoding RNAs. Nucleic Acids Res (2010) 4.49
Bidirectional transcription directs both transcriptional gene activation and suppression in human cells. PLoS Genet (2008) 4.45
Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer (2009) 4.40
YY1 tethers Xist RNA to the inactive X nucleation center. Cell (2011) 4.06
The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer? EMBO Rep (2010) 4.05
Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol (2011) 3.88
GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene (2008) 3.79
The H19 non-coding RNA is essential for human tumor growth. PLoS One (2007) 3.75
Differentiating protein-coding and noncoding RNA: challenges and ambiguities. PLoS Comput Biol (2008) 3.66
Large non-coding RNAs: missing links in cancer? Hum Mol Genet (2010) 3.49
Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA. Science (2010) 3.45
The reality of pervasive transcription. PLoS Biol (2011) 3.41
The relationship between non-protein-coding DNA and eukaryotic complexity. Bioessays (2007) 3.41
Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res (2011) 3.38
Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. Cancer Cell (2006) 3.29
NONCODE: an integrated knowledge database of non-coding RNAs. Nucleic Acids Res (2005) 3.16
Retracted Induction of DNA methylation and gene silencing by short interfering RNAs in human cells. Nature (2004) 3.12
An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature (2009) 3.04
Antisense transcripts are targets for activating small RNAs. Nat Struct Mol Biol (2008) 3.02
Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell (2001) 2.86
Controlling gene expression in living cells through small molecule-RNA interactions. Science (1998) 2.72
Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis (2009) 2.45
P53 mRNA controls p53 activity by managing Mdm2 functions. Nat Cell Biol (2008) 2.43
aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia. J Natl Cancer Inst (1999) 2.39
Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract. Nat Med (2005) 2.30
RNAdb 2.0--an expanded database of mammalian non-coding RNAs. Nucleic Acids Res (2006) 2.27
BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell (2002) 2.24
NRED: a database of long noncoding RNA expression. Nucleic Acids Res (2008) 2.21
NFAT proteins: emerging roles in cancer progression. Nat Rev Cancer (2009) 2.18
A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster. Blood (2009) 2.18
PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc Natl Acad Sci U S A (2000) 2.17
UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett (2008) 2.14
Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3. J Am Chem Soc (2009) 2.06
SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA (2011) 2.03
Long, abundantly expressed non-coding transcripts are altered in cancer. Hum Mol Genet (2007) 2.00
Characterization of the RNA content of chromatin. Genome Res (2010) 1.99
The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci U S A (2008) 1.98
Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res (2006) 1.97
A noncoding RNA is a potential marker of cell fate during mammary gland development. Proc Natl Acad Sci U S A (2006) 1.94
fRNAdb: a platform for mining/annotating functional RNA candidates from non-coding RNA sequences. Nucleic Acids Res (2006) 1.94
HOX and non-HOX homeobox genes in leukemic hematopoiesis. Stem Cells (2002) 1.94
Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc Natl Acad Sci U S A (2010) 1.87
Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur J Gastroenterol Hepatol (2009) 1.85
SNPs in ultraconserved elements and familial breast cancer risk. Carcinogenesis (2008) 1.84
Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res (2010) 1.81
Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology (2009) 1.78
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet (1995) 1.77
A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res (2009) 1.77
Role of human noncoding RNAs in the control of tumorigenesis. Proc Natl Acad Sci U S A (2009) 1.76
Involvement of argonaute proteins in gene silencing and activation by RNAs complementary to a non-coding transcript at the progesterone receptor promoter. Nucleic Acids Res (2010) 1.74
Expression of neural BC200 RNA in human tumours. J Pathol (1997) 1.70
Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection. RNA (2010) 1.66
LINE-1 hypomethylation during primary colon cancer progression. PLoS One (2011) 1.66
CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene (2010) 1.65
MEG3 imprinted gene contribution in tumorigenesis. Int J Cancer (2011) 1.61
A discontinuous hammerhead ribozyme embedded in a mammalian messenger RNA. Nature (2008) 1.58
Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription. Nucleic Acids Res (2009) 1.55
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene (2008) 4.11
miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ (2009) 3.94
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene (2007) 3.29
MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene (2007) 2.79
A microRNA component of the hypoxic response. Cell Death Differ (2008) 2.59
miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ (2009) 1.82
CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene (2010) 1.65
MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia (2008) 1.53
Interferon treatment of NZB mice: accelerated progression of autoimmune disease. Infect Immun (1978) 1.53
Structural and functional features of the alpha 3 chain indicate a bridging role for chicken collagen VI in connective tissues. Biochemistry (1990) 1.45
Expression of the monomeric 67-kd laminin-binding protein in human lymphomas as defined by MLuC5 monoclonal antibody and paraffin section immunohistochemistry. Hum Pathol (1995) 1.45
p27(kip1) functional regulation in human cancer: a potential target for therapeutic designs. Curr Med Chem (2005) 1.23
EMI, a novel cysteine-rich domain of EMILINs and other extracellular proteins, interacts with the gC1q domains and participates in multimerization. FEBS Lett (2000) 1.23
Regulated expression of fibronectin, laminin and related integrin receptors during the early chondrocyte differentiation. J Cell Sci (1997) 1.20
Murine cell surface glycoproteins. Purification of the polymorphic Pgp-1 antigen and analysis of its expression on macrophages and other myeloid cells. J Biol Chem (1983) 1.20
Avian neural crest cell migration is diversely regulated by the two major hyaluronan-binding proteoglycans PG-M/versican and aggrecan. Development (2000) 1.19
Differential role of distinct determinants of intercellular adhesion molecule-1 in immunologic phenomena. J Immunol (1989) 1.17
Isolation and characterization of a 115,000-dalton matrix-associated glycoprotein from chick aorta. J Biol Chem (1983) 1.12
An 'environment to nucleus' signaling system operates in B lymphocytes: redox status modulates BSAP/Pax-5 activation through Ref-1 nuclear translocation. Nucleic Acids Res (2000) 1.09
Emilin, a component of elastic fibers preferentially located at the elastin-microfibrils interface. J Cell Biol (1993) 1.08
Identification of domains responsible for von Willebrand factor type VI collagen interaction mediating platelet adhesion under high flow. J Biol Chem (1999) 1.07
Gene for a major cell surface glycoprotein of mouse macrophages and other phagocytic cells is on chromosome 2. Proc Natl Acad Sci U S A (1982) 1.05
Targeting microRNAs with small molecules: from dream to reality. Clin Pharmacol Ther (2010) 1.04
The carboxyl terminus of the chicken alpha 3 chain of collagen VI is a unique mosaic structure with glycoprotein Ib-like, fibronectin type III, and Kunitz modules. J Biol Chem (1989) 1.03
The role of microRNA in human leukemia: a review. Leukemia (2009) 1.03
EMILIN, a component of the elastic fiber and a new member of the C1q/tumor necrosis factor superfamily of proteins. J Biol Chem (1999) 1.02
Monoclonal antibodies against ricin: effects on toxin function. Hybridoma (1986) 1.02
Glycoprotein 115, a glycoprotein isolated from chick blood vessels, is widely distributed in connective tissue. J Cell Biol (1985) 1.01
Expression of myelomonocytic antigens is associated with unfavourable clinicoprognostic factors in B-cell chronic lymphocytic leukaemia. Ann Oncol (1991) 1.00
MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway. Oncogene (2011) 1.00
Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas. Proc Natl Acad Sci U S A (2000) 0.99
Persistent expansions of CD4+ CD8+ peripheral blood T cells. Blood (1993) 0.99
Isolation and characterization of EMILIN-2, a new component of the growing EMILINs family and a member of the EMI domain-containing superfamily. J Biol Chem (2001) 0.98
Use of reflexology foot massage to reduce anxiety in hospitalized cancer patients in chemotherapy treatment: methodology and outcomes. J Nurs Manag (2006) 0.98
Phenotypic heterogeneity of persistent expansions of CD4+ CD8+ T cells. Clin Immunol Immunopathol (1994) 0.97
Alpha 1 chain of chick type VI collagen. The complete cDNA sequence reveals a hybrid molecule made of one short collagen and three von Willebrand factor type A-like domains. J Biol Chem (1989) 0.97
The human type VI collagen gene. mRNA and protein variants of the alpha 3 chain generated by alternative splicing of an additional 5-end exon. J Biol Chem (1992) 0.96
Self-assembly and supramolecular organization of EMILIN. J Biol Chem (2000) 0.95
HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts. Cell Death Differ (2013) 0.94
H-2-dependent regulation of the high level of expression of ecotropic murine leukemia virus. J Natl Cancer Inst (1979) 0.94
Type VI collagen expression is upregulated in the early events of chondrocyte differentiation. Development (1993) 0.92
Abnormal RNA expression of 11p15 imprinted genes and kidney developmental genes in Wilms' tumor. Cancer Res (2000) 0.89
Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders. Blood (1990) 0.89
Elastic fiber proteins in the glomerular mesangium in vivo and in cell culture. Kidney Int (2000) 0.87
Chronic lymphocytic leukemia: molecular genetics and animal models. Curr Top Microbiol Immunol (2005) 0.87
Laminin isoforms 8 and 10 are primary components of the subendothelial basement membrane promoting interaction with neoplastic lymphocytes. Cancer Res (2001) 0.87
The human alpha3b is a 'full-sized' laminin chain variant with a more widespread tissue expression than the truncated alpha3a. FEBS Lett (1997) 0.87
Age dependence and genetics of expression of ecotropic murine leukemia virus in SJL/J mice. J Natl Cancer Inst (1979) 0.86
Genomic analysis of collagen and endogenous virus loci in the UCD-200 and 206 lines of chickens, animal models for scleroderma. J Autoimmun (1995) 0.86
Multiple forms of chicken alpha 3(VI) collagen chain generated by alternative splicing in type A repeated domains. J Cell Biol (1990) 0.85
A radioimmunoassay for virus antibody using binding of 125I-labelled protein A. J Gen Virol (1979) 0.85
Spontaneous lymphomas in SJL/J-(v+) mice: ecotropic and dualtropic virus expression in normal and lymphomatous tissues. J Natl Cancer Inst (1981) 0.85
5-Aza-2'-deoxycytidine as a differentiation inducer in acute myeloid leukaemias and myelodysplastic syndromes of the elderly. Bone Marrow Transplant (1989) 0.84
Immune reactivity in the Moloney strain of murine sarcoma virus oncogenesis: requirement of thymus-derived lymphocytes for in vivo protection. J Natl Cancer Inst (1976) 0.84
Ovotransferrin and ovotransferrin receptor expression during chondrogenesis and endochondral bone formation in developing chick embryo. J Cell Biol (1994) 0.84
Extracellular matrix modifications in the interdigital spaces of the chick embryo leg bud during the formation of ectopic digits. Anat Embryol (Berl) (1996) 0.83
Structure, chromosomal localization, and promoter analysis of the human elastin microfibril interfase located proteIN (EMILIN) gene. J Biol Chem (2000) 0.83
Identification of a mouse gene required for binding of Rauscher MuLV envelope gp70. Somatic Cell Genet (1979) 0.82
Effect of endogenous and exogenous murine leukemia virus infection on immunologic response. Eur J Cancer (1975) 0.82
Centrifugal assay for fluorescence-based cell adhesion adapted to the analysis of ex vivo cells and capable of determining relative binding strengths. Biotechniques (1999) 0.82
Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier. J Natl Cancer Inst (1978) 0.82
Generation of cytotoxic cells in absence of blastogenesis by mouse leukemic cells in mixed cultures. Eur J Immunol (1976) 0.81
Fibronectin binding promotes a PKC-dependent modulation of NF-kappa B in human T cells. Biochem Biophys Res Commun (1998) 0.80
c-fos oncogene expression in human hematopoietic malignancies is restricted to acute leukemias with monocytic phenotype and to subsets of B cell leukemias. Blood (1987) 0.80
Genetic control of oncogenesis by murine sarcoma virus Moloney pseudotype. I. Genetics of resistance in AKR mice. Int J Cancer (1975) 0.80
Adhesion to fibronectin promotes the activation of the p125(FAK)/Zap-70complex in human T cells. Immunology (1999) 0.80
T lymphocyte requirement for MSV tumour prevention or regression. Nature (1974) 0.79
Monoclonal antibodies against chick gp 115, a matrix glycoprotein with broad distribution. Coll Relat Res (1985) 0.79
Differential attachment of human neoplastic B cells to purified extracellular matrix molecules. Blood (1994) 0.79
In vitro and in vivo evaluation of T and B lymphocyte functions in AKR mice. Br J Cancer (1975) 0.78
Myofibroblasts and extracellular matrix glycoproteins in palmar fibromatosis. Gen Diagn Pathol (1997) 0.78
S-100 protein, fibronectin, and laminin immunostaining in lymphomas of follicular center cell origin. Cancer (1986) 0.78
Cloning and characterization of cDNAs expressed during chick development and encoding different isoforms of a putative zinc finger transcriptional regulator. Biochimie (2005) 0.78
Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes. J Exp Med (1974) 0.78
Bidirectional induction of the cognate receptor-ligand alpha4/VCAM-1 pair defines a novel mechanism of tumor intravasation. Blood (2000) 0.78
Differential cation regulation of the alpha 5 beta 1 integrin-mediated adhesion of leukemic cells to the central cell-binding domain of fibronectin. Cell Growth Differ (1997) 0.77
In vivo interactions between murine leukemia and sarcoma viruses. Bibl Haematol (1975) 0.77
Lack of T-cell mediated cytotoxicity in M-MSV system depending on H-2 haplotypes. J Immunogenet (1979) 0.77
Interactions of promonocytic U937 cells with proteins of the extracellular matrix. Immunology (1993) 0.77
Alternative splicing of VWFA modules generates variants of type VI collagen alpha 3 chain with a distinctive expression pattern in embryonic chicken tissues and potentially different adhesive function. Matrix Biol (1998) 0.77
Prevention of murine sarcoma virus oncogenesis in offspring of immunized female mice. Br J Cancer (1973) 0.77
Identification of an active Chi recombinational hot spot within the HIV-1 envelope gene: consequences for development of AIDS vaccines. Vaccine (1999) 0.76
Isolation of cDNA clones corresponding to the Mr = 150,000 subunit of chick type VI collagen. Biochem Biophys Res Commun (1987) 0.76
Immunohistochemical distribution of type VI collagen in developing human kidney. Histochem J (1996) 0.76
Inhibitory effect of YC8 leukaemia cell line on in vitro lymphocyte reactivity. Br J Cancer (1977) 0.75
Basement membrane components in lymphoid follicles: immunohistochemical demonstration and relationship to the follicular dendritic cell network. Hum Pathol (1989) 0.75
[Protective action of polyinosinic-polycytidylic acid in viral and transplanted leukemia in mice]. Tumori (1973) 0.75
Differentiation of human leukaemic cell lines and fresh leukaemia cells by low dose Ara-C: monitoring by expression of c-myc and c-fos oncogenes. Med Oncol Tumor Pharmacother (1988) 0.75
Multiple binding reactivities of an IgG1 mouse monoclonal antibody raised against the extracellular matrix glycoprotein Gp 115. Hybridoma (1987) 0.75
Monoclonal antibody detection of naphthalene dioxygenase from Pseudomonas aeruginosa 2NR. Lett Appl Microbiol (2000) 0.75
Efficient expression of chicken alpha 1(VI) collagen chain in transiently transfected mammalian cells. Matrix (1990) 0.75
Genetic control of oncogenesis by murine sarcoma virus Moloney pseudotype. II. A dominant epistatic susceptibility gene. Int J Cancer (1975) 0.75
A solid-phase receptor binding assay for 125I-hCG. J Immunoassay (1987) 0.75
Expression and distribution of type VI collagen in gynecomastia. Acta Histochem (1994) 0.75
False promises for European space science. Science (2001) 0.75
Thy 1.2+ leukemia cells eradicated from in vitro leukemia-bone marrow cell mixtures by antibody-toxin conjugates. J Natl Cancer Inst (1984) 0.75
Immune response and leukemia virus infection in the mouse. Boll Ist Sieroter Milan (1974) 0.75
Humanized antibodies as potential drugs for therapeutic use. Adv Clin Path (2000) 0.75
Immunohistochemical staining patterns of type VI collagen in the normal, hyperplastic, and neoplastic adult male breast. Pathologica (1994) 0.75